DK33792A - Krystalform af aminoalkylfuranderivat - Google Patents

Krystalform af aminoalkylfuranderivat Download PDF

Info

Publication number
DK33792A
DK33792A DK033792A DK33792A DK33792A DK 33792 A DK33792 A DK 33792A DK 033792 A DK033792 A DK 033792A DK 33792 A DK33792 A DK 33792A DK 33792 A DK33792 A DK 33792A
Authority
DK
Denmark
Prior art keywords
aminoal
crystal form
reference derivative
cool
cool reference
Prior art date
Application number
DK033792A
Other languages
English (en)
Other versions
DK167923B1 (da
DK33792D0 (da
Inventor
Derek Leslie Crookes
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10516407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK33792(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK33792A publication Critical patent/DK33792A/da
Publication of DK33792D0 publication Critical patent/DK33792D0/da
Application granted granted Critical
Publication of DK167923B1 publication Critical patent/DK167923B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
DK033792A 1980-10-01 1992-03-12 Ranitidinhydrochlorid i form 2 og anvendelsen deraf ved fremstilling af et farmaceutisk praeparat DK167923B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8031634 1980-10-01
GB8031634 1980-10-01

Publications (3)

Publication Number Publication Date
DK33792A true DK33792A (da) 1992-03-12
DK33792D0 DK33792D0 (da) 1992-03-12
DK167923B1 DK167923B1 (da) 1994-01-03

Family

ID=10516407

Family Applications (2)

Application Number Title Priority Date Filing Date
DK436281A DK167794B1 (da) 1980-10-01 1981-10-01 Fremgangsmaade til fremstilling af en krystalform af ranitidinhydrochlorid
DK033792A DK167923B1 (da) 1980-10-01 1992-03-12 Ranitidinhydrochlorid i form 2 og anvendelsen deraf ved fremstilling af et farmaceutisk praeparat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK436281A DK167794B1 (da) 1980-10-01 1981-10-01 Fremgangsmaade til fremstilling af en krystalform af ranitidinhydrochlorid

Country Status (29)

Country Link
US (2) US4521431A (da)
JP (1) JPS5791983A (da)
KR (1) KR870001431B1 (da)
AT (1) AT389696B (da)
AU (1) AU549119B2 (da)
BE (1) BE890574A (da)
CA (1) CA1202638A (da)
CH (1) CH652122A5 (da)
CZ (1) CZ280885B6 (da)
DE (1) DE3139134A1 (da)
DK (2) DK167794B1 (da)
ES (1) ES505951A0 (da)
FR (1) FR2491067A1 (da)
GR (1) GR72499B (da)
HK (1) HK97985A (da)
IE (1) IE51604B1 (da)
IL (1) IL63968A (da)
IT (1) IT1143237B (da)
KE (1) KE3549A (da)
LU (1) LU83661A1 (da)
MY (1) MY8500747A (da)
NL (1) NL8104482A (da)
NZ (1) NZ198522A (da)
PH (2) PH19489A (da)
PT (1) PT73744B (da)
SE (1) SE453500B (da)
SK (1) SK277922B6 (da)
ZA (1) ZA816809B (da)
ZW (1) ZW24481A1 (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR242029A1 (es) * 1983-07-15 1993-02-26 Richter Gedeon Vegyeszet Procedimiento para la preparacion del clorhidrato de 1-(2-(5- dimetilaminometil-2-(furilmetiltio)-etil))-amino-1-metilamino-2-nitroetileno
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
SE8704436D0 (sv) * 1987-11-13 1987-11-13 Pm Konsult Handelsbolag Anvendning av antisekretoriska substanser for nya indikationer
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
CN1048984C (zh) * 1991-12-20 2000-02-02 多坎化学有限公司 晶形1呋喃硝胺氢氯化物的制备
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride
ATE202109T1 (de) * 1993-03-12 2001-06-15 Upjohn Co Kristallines ceftiofur (freie säure)
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
EP0754182A1 (en) * 1994-04-08 1997-01-22 Brantford Chemicals Inc. Form 1 ranitidine hydrochloride with increased density
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
DE69523447T2 (de) 1994-04-15 2002-05-16 Pharmacia & Upjohn Co., Kalamazoo Kristallformen von 1-[5-methansulfonamidoindolyl-2-carbonyl]-4-[3-[1-methylethylamino]-2-pyridinyl] piperazin
IN181699B (da) * 1994-05-13 1998-09-05 Ranbaxy Lab Ltd
NZ272054A (en) * 1994-05-13 1996-05-28 Ranbaxy Lab Ltd Process for producing form 1 ranitidine hydrochloride
IN181698B (da) * 1994-05-13 1998-09-05 Ranbaxy Lab Ltd
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
CN1623985A (zh) * 1994-05-18 2005-06-08 阿温蒂斯药物公司 抗组胺哌啶衍生物，其多晶形物和假同晶物的无水和水合物形式的制备方法
EP0694540B1 (en) 1994-06-24 1998-08-19 Ranbaxy Laboratories Limited Process for the manufacture of form 1 ranitidine hydrochloride
EP0790992A1 (en) * 1994-11-18 1997-08-27 PHARMACIA & UPJOHN COMPANY A new physically stable solid form of a fluoroquinolone
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5663381A (en) * 1995-04-21 1997-09-02 Hexal Pharmaceuticals, Inc. Process for preparing form 1 ranitidine hydrochloride
US5686588A (en) * 1995-08-16 1997-11-11 Yoo; Seo Hong Amine acid salt compounds and process for the production thereof
WO1997035853A1 (en) * 1996-03-25 1997-10-02 Hoechst Marion Roussel, Inc. Process for the preparation of form 1 ranitidine hydrochloride
ATE207065T1 (de) * 1997-08-08 2001-11-15 Aventis Pharma Gmbh Kristallform von n-(4-trifluormethylphenyl)-5- methylisoxazol-4-carbonsäureamid
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
IT1317858B1 (it) 2000-02-29 2003-07-15 Pharmexcel S R L Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20060173064A1 (en) * 2001-08-24 2006-08-03 Lippa Arnold S (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
AR040661A1 (es) * 2002-07-26 2005-04-13 Theravance Inc Diclorhidrato cristalino de n-{2-[-((r)-2-hidroxi-2-feniletilamino)fenil]etil}-(r)-2hidroxi-2-(3-formamido-4-hidroxifenil)etilamina, agonista del receptor adrenergico beta 2
US20080081834A1 (en) 2002-07-31 2008-04-03 Lippa Arnold S Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
RU2005117630A (ru) * 2002-11-08 2006-01-20 Дов Фармасьютикал, Инк. (Us) Полиморфы гидрохлорида бицифадина
TW200510277A (en) * 2003-05-27 2005-03-16 Theravance Inc Crystalline form of β2-adrenergic receptor agonist
US7384557B2 (en) * 2003-07-14 2008-06-10 Applied Ambient Extraction Process Consultants, Llc Method and apparatus for removing solute from a solid solute-bearing product
TWI328006B (en) 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
ZA200801825B (en) 2005-07-27 2009-12-30 Dov Pharmaceutical Inc Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: Preparation and use to treat neuropsychiatric disorders
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
EP2330101A1 (en) * 2006-10-20 2011-06-08 Scinopharm Singapore Pte, Ltd. Process for making crystalline docetaxel
US8138377B2 (en) 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
WO2008153937A2 (en) * 2007-06-06 2008-12-18 Dov Pharmaceutical, Inc. Novel 1- heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
TW201011043A (en) * 2008-06-20 2010-03-16 Chugai Pharmaceutical Co Ltd Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
PL2727912T3 (pl) 2011-06-30 2017-12-29 Toray Industries, Inc. Kryształy pochodnej glicyny i ich zastosowanie farmaceutyczne
US20140206740A1 (en) 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
CN106432147B (zh) * 2015-05-26 2018-04-17 烟台市华文欣欣医药科技有限公司 一种制备治疗胃病的药物盐酸雷尼替丁化合物的方法
CN105030694A (zh) * 2015-08-04 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种治疗胃溃疡的药物盐酸雷尼替丁组合物干混悬剂
CN104971053A (zh) * 2015-08-05 2015-10-14 青岛蓝盛洋医药生物科技有限责任公司 一种治疗消化系统疾病的药物盐酸雷尼替丁组合物片剂
CN105055331A (zh) * 2015-08-31 2015-11-18 青岛蓝盛洋医药生物科技有限责任公司 一种治疗消化性溃疡的药物盐酸雷尼替丁组合物颗粒剂
WO2021079183A1 (en) * 2019-10-21 2021-04-29 Sms Pharmaceuticals Limited Isopropyl alcohol solvent free crystalline ranitidine hydrochloride form-2 which is free of nitrosamine (ndma) impurity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IL63968A (en) 1985-10-31
IL63968A0 (en) 1981-12-31
PT73744A (en) 1981-10-01
FR2491067B1 (da) 1984-09-07
KE3549A (en) 1985-08-16
SK403591A3 (en) 1995-08-09
IT8149407A0 (it) 1981-10-01
SE453500B (sv) 1988-02-08
PH19489A (en) 1986-05-14
AU549119B2 (en) 1986-01-16
SE8105812L (sv) 1982-04-02
GR72499B (da) 1983-11-15
SK277922B6 (en) 1995-08-09
NL8104482A (nl) 1982-05-03
ES8301954A1 (es) 1983-01-01
JPH0443070B2 (da) 1992-07-15
NZ198522A (en) 1985-07-12
MY8500747A (en) 1985-12-31
AT389696B (de) 1990-01-10
IE812287L (en) 1982-04-01
ZW24481A1 (en) 1983-04-27
CA1202638A (en) 1986-04-01
CZ280885B6 (cs) 1996-04-17
KR870001431B1 (ko) 1987-08-06
IE51604B1 (en) 1987-01-21
IT1143237B (it) 1986-10-22
AU7595581A (en) 1982-04-08
DK167794B1 (da) 1993-12-13
ATA422281A (de) 1989-06-15
US4672133A (en) 1987-06-09
PH21761A (en) 1988-02-18
DK167923B1 (da) 1994-01-03
CH652122A5 (fr) 1985-10-31
FR2491067A1 (fr) 1982-04-02
LU83661A1 (fr) 1983-06-08
DK436281A (da) 1982-04-02
US4521431A (en) 1985-06-04
PT73744B (en) 1983-10-31
HK97985A (en) 1985-12-13
DE3139134C2 (da) 1990-04-19
CZ403591A3 (en) 1994-01-19
KR830007070A (ko) 1983-10-14
DK33792D0 (da) 1992-03-12
BE890574A (fr) 1982-04-01
JPS5791983A (en) 1982-06-08
ZA816809B (en) 1983-05-25
ES505951A0 (es) 1983-01-01
DE3139134A1 (de) 1982-05-19

Similar Documents

Publication Publication Date Title
DK33792D0 (da) Krystalform af aminoalkylfuranderivat
DK163243C (da) Fremgangsmaade til fremstilling af cephalosporinderivater
FI813531L (fi) Foerfarande foer framstaellning av en kornformig laekemedelsform med foerdroejd avgivning
DK205284D0 (da) Kompleksforbindelser af technetium-9m med alkylenaminoximer
FI813049L (fi) Framstaellning av silanmodifierade copolymerer av alkylen-alkyl-akrylater polysiloxaner i vilka ingaor organo-titanater och anvaendning av dessa vid framstaellning av silanmodifierade copolymerer av alkylen-alkyl-akrylater
DK400081A (da) Fremgangsmaade til fremstilling af phenylpiperazinderivater
DK229879A (da) R fremgangsmaade til fremstilling af n-alkylerede aminoalkohole
DK214778A (da) Fremgangsmaade til fremstilling af aminoalkylthiophenderivater
DK214878A (da) Fremgangsmaade til fremstilling af aminoalkylbenzenderivater
DK319281A (da) Femgangsmaade til fremstilling af benzisoselenazoloner
FI834771A0 (fi) Kristalliserade kefem-syraadditionssalter och foerfarande foer deras framstaellning
DK5981A (da) Fremgangsmaade til undgaaelse af krystallisation af (%n!-diphenylen-bis-imider i termohaerdelige formstoffer indeholdende disse bis-imider
DK101980A (da) Femgangsmaade til fremstilling af antisecretorisk virksomme forbindelser
DK103380A (da) Fremgangsmaade til femstilling af 9-aminoalkylfluorener
FI800455A7 (fi) Spaerranordning vid ett utmatningsmagasin foer behaollare
DK454085A (da) Monotertiaeralkylderivater af toluendiamin
DK216681A (da) Fremgangsmaade til fremstilling af antitumormidler
FI834033L (fi) Foerfarande och anordning foer framstaellning av med foerstorad bas foersedda pao plats gjorda betongpaolar
FI832919A0 (fi) Foerfarande foer framstaellning av n-substituerad nikotinamid-1-oxid och dess salter
DK338780A (da) Phosphorestere af alkylcykloalkyl-5-pyrimidinoler
FI824077A0 (fi) Foerfarande och anordning foer framstaellning av en optisk glasfiber med laog oh -jonhalt
DK133081A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK156732C (da) Fremgangsmaade til fremstilling af splitbaand
NO840184L (no) Fremgangsmaate for dekarboksylering av et alkylformiat
DK371679A (da) Fremgangsmaade til fremstilling af substituerede aminoalkylguanidiner

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired